DJO Global reported net sales growth during the third quarter of 2014, but also reported net loss.
Here are 10 things to know about the company's financial report:
1. Net loss attributed to DJO Finance, the company's public reporting subsidiary, was $21.2 million, up from the $18.5 million net loss reported for the same period last year.
2. Significant non-cash items, non-recurring items and other adjustments had an impact on the company's financial report.
3. DJOFL reported net sales at $305.5 million, a 6.1 percent growth from the same period in 2013.
4. The adjusted EBITDA for the third quarter was $70.2 million, or 23 percent of net sales.
5. The surgical implant segment reported $23.8 million in net sales for the quarter, a 19 percent growth over the same period last year.
6. Surgical implant growth was driven by strong shoulder, knee and hip product line sales.
7. Cash balances were $40.9 million as of Sept. 27 and available liquidity was $89.5 million under its $100 million revolving line of credit.
8. For the nine months end, the company reported $902 million in net sales.
9. Gross profit for the third quarter was $182.8 million.
10. Operating income for the quarter was $26.8 million, up slightly from the same period last year.